MediFransk ApS: Financial statements 2023
CVR: 40780904
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MediFransk ApS (CVR 40780904) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 408,013 and a net result of DKK -14,102 compared with DKK -8,997 the year before. That is a decrease of 32.9% compared with the year before. Equity in the 2023 report amounted to DKK 19,308. The solvency ratio was 13.7%.
- Gross Profit
- DKK 408,013
- Profit/Loss
- DKK -14,102
- Equity
- DKK 19,308
- Total Assets
- DKK 141,042
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 408 t. | -14 t. | 19 t. | - |
| 2022 | - | 608 t. | -9 t. | 33 t. | - |
| 2021 | - | 457 t. | 2 t. | 42 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
MediFransk ApS has published its annual report for 2022. Gross profit came to DKK 608,378, and the net result was DKK -8,997.
About MediFransk ApS
MediFransk ApS is a Danish company of the type Anpartsselskab based in Ålsgårde, founded in 2019. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Frédéric Pierre Louis Bernard. The company is owned by BERNARD Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 485,515 and a net result of DKK 104,261 compared with DKK 50,715 the year before. Equity in the 2025 report amounted to DKK 174,291.